9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
Topic archive
share exchange
2 stories
9/23/2026
Psyence and PsyLabs share exchange to boost ibogaine research
Psyence and PsyLabs collaborate to advance ibogaine for opioid use disorder.